Koyfin Home > Directory > Health Care > Horizon Therapeutics > Debt Issued

Horizon Therapeutics Debt Issued Chart (HZNP)

Horizon Therapeutics annual/quarterly Debt Issued from 2010 to 2019.
  • Horizon Therapeutics Debt Issued for the quarter ending December 12, 2019 was $418m a -95.69% decrease of -400m year over year
  • Horizon Therapeutics Debt Issued for the last 12 months ending September 09, 2020 was $418m a -264.92% decrease of -1,107m year over year
  • Horizon Therapeutics Annual Debt Issued for 2019 was $1,525m a 46.38% increase of 707m from 2018
  • Horizon Therapeutics Annual Debt Issued for 2018 was $818m a -107.02% decrease of -875m from 2017
  • Horizon Therapeutics Annual Debt Issued for 2017 was $1,694m a 61.25% increase of 1,037m from 2016
Other Cash Flow Metrics:
  • Horizon Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $109m a 155.94% increase of 170m year over year
  • Horizon Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $126m a 125.54% increase of 158m year over year
  • Horizon Therapeutics Total Revenue for the quarter ending December 12, 2018 was $356m a 37.03% increase of 132m year over year
View Chart On Koyfin

Quarterly HZNP Debt Issued Data

12/2019$418m
09/2019$590m
06/2019$517m
12/2018$818m
12/2017$846m
09/2017$0m
06/2017$0m
03/2017$848m
12/2016$656m
12/2015$0m

Annual HZNP Debt Issued Data

2019$1,525m
2018$818m
2017$1,694m
2016$656m
2015$1,241m
2014$287m
2013$144m
2012$56m
2011$23m
2010$20m